Vortex Pharma Solution ApS: Financial statements 2024
CVR: 43009672
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Vortex Pharma Solution ApS (CVR 43009672) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 613,162 and a net result of DKK 302,635 compared with DKK -294,926 the year before. Equity in the 2024 report amounted to DKK 145,994. The solvency ratio was 28.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 613,162
- Profit/Loss
- DKK 302,635
- Equity
- DKK 145,994
- Total Assets
- DKK 514,554
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 613 t. | 303 t. | 146 t. | 2 |
| 2023 | - | -59 t. | -295 t. | -157 t. | 2 |
| 2022 | - | 319 t. | 173 t. | 213 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Vortex Pharma Solution ApS has published its annual report for 2023. Gross profit came to DKK -59,473, and the net result was DKK -294,926.
About Vortex Pharma Solution ApS
Vortex Pharma Solution ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2022. The company is registered under the industry Anden teknisk rådgivning. The management consists of Flavia Christina Ladwig Robles. The company is owned by Vortex Holdings ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 255,541 and a net result of DKK -34,561 compared with DKK 302,635 the year before. Equity in the 2025 report amounted to DKK 111,433.